MDIC Lays Out Five-Step Cybersecurity Penetration Testing Process For Connected Device Makers
MDIC's new penetration testing guidance argues manufacturers often miscalibrate how they test connected devices and lays out a five-step framework to fix it, as regulatory submissions increasingly demand pen-test evidence.
Medtech Insight - July 6, 2026

Firms Recently Issued FDA Warning Letters Include ZOLL, Medline, Happiest Baby
The US Food and Drug Administration has posted seven warning letters in recent weeks,
Medtech Insight - July 6, 2026

Novartis Bets $1.1bn Upfront On New Class Of ADC Payloads With Myricx Buyout
Novartis is paying $1.1bn upfront for UK biotech Myricx Bio and its novel NMT-inhibitor ADC payload platform, betting it can build an oncology franchise as it did in radioligand therapy.
Scrip - July 6, 2026

US Senator Presses Merck Over Keytruda Patents Limiting Biosimilar Competition
Merck’s CEO promised not to hinder biosimilar competition for its Keytruda IV. With two years left until the market opens, a US senator demands answers.
Generics Bulletin - July 6, 2026

Pipeline Watch: Eight Approvals And Fourteen Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Scrip - July 6, 2026

Synthon Adds Capacity With Spanish Acquisition
Synthon has announced a significant expansion of its development and manufacturing capabilities for complex generics through the acquisition of a site adjacent to its existing Spanish operations in Sant Boi.
Generics Bulletin - July 6, 2026

Novo Nordisk Goes Direct To Patient With UK Wegovy Pill Launch
Following a record-breaking start in the US, the firm’s once-a-day oral therapy is now available in the UK but only on private prescription.
Scrip - July 6, 2026

Beyond Beauty: Consumers View Personal Care As A Pillar Of Health And Longevity
European consumers increasingly view personal care products as part of preventive health, not just appearance. A pan-European study from Cosmetics Europe finds consumers link daily personal care routines to long-term wellbeing, pointing to important policy considerations for the EU.
HBW Insight - July 6, 2026

Beyond Rare: Nucleic Acid Therapeutics Are Targeting The Cardiovascular Mainstream
Nucleic acid therapeutics have so far been overwhelmingly a rare-disease modality but a pipeline of more than 30 candidates is now pushing into mainstream cardiovascular indications such as hypertension, elevated lipoprotein(a), and broad dyslipidaemia.
In Vivo - July 6, 2026

Podcast: Tonix’s Bet on Monoclonal Prevention Of Lyme Disease
If approved, TNX-4800, Tonix's monoclonal antibody against Lyme disease, would offer rapid seasonal protection where vaccines have repeatedly struggled. A Phase II field study is planned for 2027.
In Vivo - July 6, 2026

EU’s AI Medtech Rules Are Set; The Machinery To Deliver Them Isn’t
EU-wide fragmentation in reimbursement, certification processes and data governance could scupper the AI Act’s single market ambitions, says a new report.
Medtech Insight - July 6, 2026